Effect of Omega-3 and Probiotic Dietary Supplements on Elevated High Sensitivity C-reactive Protein (Hs-CRP) as a Marker of Low-grade Inflammation

NACompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

September 11, 2019

Primary Completion Date

May 15, 2020

Study Completion Date

December 15, 2020

Conditions
Inflammation
Interventions
DIETARY_SUPPLEMENT

Probiotic, Omega-3, Vitamin D supplement

"The first supplement we would like to assess is named VNP and is composed by Omega-3 Active and vitamin D. It contains a total of 1100 mg fish oils: 640 mg Omega-3 and with 300 mg eicosapentaenoic acid (EPA), 220 mg docosahexaenoic acid (DHA) plus 200 IU Vitamin D per daily dose (2 capsules).~The second supplement we investigate is four-strain probiotics combination based on the commercially available formulation HOWARU® by DuPont; two capsules containing 10 billion CFU total (supplied by Pfizer but manufactured by Danisco, DuPont). The probiotic specific composition, contains equal amounts of each strain per capsule (1.25 x 109 CFU each): Bifidobacterium lactis Bi-07, Lactobacillus paracasei Lpc-37, Lactobacillus acidophilus NCFM, Bifidobacterium lactis Bl-04. One capsule contains 5 billion CFU (Swedish milliards)."

DIETARY_SUPPLEMENT

Placebo

Placebo generated for probiotic and omega-3/vitamin D supplements

Trial Locations (1)

703 62

Örebo University, Örebro

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Hohenheim

OTHER

collaborator

Pfizer

INDUSTRY

lead

Örebro University, Sweden

OTHER

NCT04126330 - Effect of Omega-3 and Probiotic Dietary Supplements on Elevated High Sensitivity C-reactive Protein (Hs-CRP) as a Marker of Low-grade Inflammation | Biotech Hunter | Biotech Hunter